Location: St. Helier, Jersey
CIK: 0001839209 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $4.939B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 20,933,277 | $3.644B | 73.8% | $73.54 | +148.1% | COM PAR $.01 | 457669307 |
| BLTE | BELITE BIO INC | 3,027,704 | $487M | 9.9% | $160.82 | — | SPONSORED ADS | 07782B104 |
| ABVX | ABIVAX SA | 3,178,501 | $440M | 8.9% | $83.33 | — | SPONSORED ADS | 00370M103 |
| — | CIDARA THERAPEUTICS INC | 997,196 | $220M | 4.5% | $59.96 | — | COM NEW | 171757206 |
| WVE | WAVE LIFE SCIENCES LTD | 7,298,421 | $125M | 2.5% | $10.16 | 0.0% | SHS | Y95308105 |
| CAPR | CAPRICOR THERAPEUTICS INC | 800,000 | $23.17M | 0.5% | $13.06 | 0.0% | COM NEW | 14070B309 |